Catalyst Wire Dossier Catalyst Wire Dossier

diphtheria-tetanus-acellular pertussis vaccine (dTpa)

diphtheria-tetanus-acellular pertussis vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for diphtheria-tetanus-acellular pertussis vaccine (dTpa), covering 2026-08-17 to 2026-08-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years [Phase 3]

See pricing